Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study

Diabetes Care

Volumn 39, Issue 2, 2016, Pages 264-270

  Rickels, Michael R ^a   Ruedy, Katrina J ^b   Foster, Nicole C ^b   Piché, Claude A ^c   Dulude, Hélène ^c   Sherr, Jennifer L ^d   Tamborlane, William V ^d   Bethin, Kathleen E ^e   DiMeglio, Linda A ^f   Wadwa, R Paul ^g   Ahmann, Andrew J ^h   Haller, Michael J ⁱ   Nathan, Brandon M ^j   Marcovina, Santica M ^k   Rampakakis, Emmanouil ^l   Meng, Linyan ^l   Beck, Roy W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c Locemia Solutions ULC   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF COLORADO DENVER   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k Northwest Lipid Metabolism and Diabetes Research Laboratories   (United States)

^l JSS Medical Research   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN; GLUCOSE BLOOD LEVEL; HORMONE;

ABDOMINAL DISCOMFORT; ADULT; ANXIETY; ARTICLE; ATTENTION DISTURBANCE; CONFUSION; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE DURATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; EDINBURGH HYPOGLYCEMIA SCALE; EYE DISEASE; EYE PAIN; FACIAL DISCOMFORT; FEMALE; GLUCOSE BLOOD LEVEL; HEAD AND NECK DISEASE; HEAD DISCOMFORT; HEADACHE; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPERHIDROSIS; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LACRIMATION; LETHARGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; NASAL DISCOMFORT; NAUSEA; NECK PAIN; NOSE DISEASE; NOSE EDEMA; NOSE OBSTRUCTION; OCULAR HYPEREMIA; OCULAR PRURITUS; OTALGIA; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINORRHEA; SIDE EFFECT; SKIN PRURITUS; SOMNOLENCE; SYNDROME; UPPER AIRWAY COUGH SYNDROME; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; HORMONES; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84962090397     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1498     Document Type: Article

References (23)

1. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
2. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA 1984;252:3378-3381
3. Slama G, Traynard PY, Desplanque N, et al. The search for an optimized treatment of hypo-glycemia. Carbohydrates in tablets, solutin, or gel for the correction of insulin reactions. Arch Intern Med 1990;150:589-593
4. Gold AE, MacLeod KM, Deary IJ, Frier BM. Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: effect of hypoglycemia un-awareness. Physiol Behav 1995;58:501-511
5. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-1572
6. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35: 1897-1901
7. Weinstock RS, Xing D, Maahs DM, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 2013;98: 3411-3419
8. Cariou B, Lièvre M, Huet D, Charbonnel B, Sert C, Gouet D. Hypoglycemia among 3048 insulin-treated patients in real life: frequency and predictive factors: results from the prospective DIALOG study. Presented at European Association for the Study of Diabetes (Abstract). Barcelona, Spain, EASD, 2013. Available from http://www.easdvirtualmeeting.org/resources/ hypoglycaemia-among-3048-insulin-treated-patients-in-real-life-frequency-and-predictive-factors-results-from-the-prospective-dialog-study-2. Accessed 3 December 2015
9. Khunti K, Alsifri S, Aronson R, et al. Self-reported hypoglycemia: A global study of 24 countries with 27,585 insulin-treated patients with diabetes: the HAT study. Diabetes Res Clin Pract 2014;106:S105-S106
10. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hy-poglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973;182: 171-173
11. Holstein A, Hammer C, Plaschke A, et al. Hormonal counterregulation during severe hy-poglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2004;112:429-434
12. Harrism G, Diment A, Sulway M, Wilkinson M. Glucagon administration-underevaluated and undertaught. Pract Diabetes Int 2001;18:22-25
13. Pontiroli AE, Alberetto M, Pozza G.Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection. Acta Diabetol Lat 1985;22:103-110
14. FreychetL, Rizkalla SW, Desplanque N, et al. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes. Lancet 1988;1:1364-1366
15. Pontiroli AE, Calderara A, Pajetta E, Alberetto M, Pozza G. Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients. Diabetes Care 1989;12:604-608
16. Slama G, Alamowitch C, Desplanque N, Letanoux M, Zirinis P. A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon. Diabetologia 1990;33: 671-674
17. Rosenfalck AM, Bendtson I, Jørgensen S, Binder C. Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients. Diabetes Res Clin Pract 1992;17: 43-50
18. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network. The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97:4383-4389
19. Novo Nordisk. GlucaGen prescribing information [Internet]. Available from http:// www.novonordiskmedicalinformation.com// file-upload/GlucaGen%20HypoKit%20Prescribing %20Information,April%202014%20.pdf. Accessed 9 September 2015
20. Locemia Solutions ULC. Safety and efficacy ofa novel glucagon formulation intype 1diabetic patients following insulin-induced hypoglycemia (AMG102) [Internet]. Available from https:// clinicaltrials.gov/ct2/show/study/NCT01556594? term=amg+medical&rank=1. Accessed 23 June 2015
21. Hepburn DA, Deary IJ, Frier BM, Patrick AW, QuinnJD, Fisher BM. Symptomsof acute insulin-induced hypoglycemia in humans with and without IDDM.Factor-analysis approach. Diabetes Care 1991;14:949-957
22. Yale JF, Piche C, Lafontaine M, et al. Needle-free nasal delivery of glucagon is superior to injectable delivery in simulated hypoglycaemia rescue. Poster presented at European Association for the Study of Diabetes (Abstract). Stockholm, Sweden, September 2015. Available from http://www.easdvirtualmeeting.org/resources/ needle-free-nasal-delivery-of-glucagon-is-superior-to-injectable-delivery-in-simulated-hypoglycaemia-rescue-3. Accessed 3 December 2015
23. Pacchioni M, Orena C, Panizza P, Cucchi E, Del Maschio A, Pontiroli AE. The hypotonic effect of intranasal and intravenous glucagon in gastrointestinal radiology. Abdom Imaging 1995;20:44-46